These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3688286)

  • 1. An international perspective on assessment of negative and positive symptoms in schizophrenia.
    Moscarelli M; Maffei C; Cesana BM; Boato P; Farma T; Grilli A; Lingiardi V; Cazzullo CL
    Am J Psychiatry; 1987 Dec; 144(12):1595-8. PubMed ID: 3688286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms.
    Phillips MR; Xiong W; Wang RW; Gao YH; Wang XQ; Zhang NP
    Acta Psychiatr Scand; 1991 Oct; 84(4):364-70. PubMed ID: 1746289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Positive and Negative Syndrome Scale--Spanish adaptation.
    Kay SR; Fiszbein A; Vital-Herne M; Fuentes LS
    J Nerv Ment Dis; 1990 Aug; 178(8):510-7. PubMed ID: 2380697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor solution of the BPRS-expanded version in schizophrenic outpatients living in five European countries.
    Ruggeri M; Koeter M; Schene A; Bonetto C; Vàzquez-Barquero JL; Becker T; Knapp M; Knudsen HC; Tansella M; Thornicroft G;
    Schizophr Res; 2005 Jun; 75(1):107-17. PubMed ID: 15820329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.
    Purnine DM; Carey KB; Maisto SA; Carey MP
    J Nerv Ment Dis; 2000 Oct; 188(10):653-61. PubMed ID: 11048814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study.
    Lima MS; Soares BG; Paoliello G; Machado Vieira R; Martins CM; Mota Neto JI; Ferrão Y; Schirmer DA; Volpe FM
    Braz J Psychiatry; 2007 Sep; 29(3):246-9. PubMed ID: 17891261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 16 systems to diagnose schizophrenia.
    Herron WG; Schultz CL; Welt AG
    J Clin Psychol; 1992 Nov; 48(6):711-21. PubMed ID: 1452759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French translation of the Chapman Social and Physical Anhedonia Questionnaire: validation of the French translation in controls and schizophrenic patients].
    Assouly-Besse F; Dollfus S; Petit M
    Encephale; 1995; 21(4):273-84. PubMed ID: 7588166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the factor structure of symptoms in patients with schizophrenia.
    Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
    Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of negative and positive symptoms in schizophrenia.
    Lewine RR; Fogg L; Meltzer HY
    Schizophr Bull; 1983; 9(3):368-76. PubMed ID: 6622994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
    Wetzel H; Hillert A; Gründer G; Benkert O
    Am J Psychiatry; 1994 Oct; 151(10):1499-502. PubMed ID: 7916543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of mood and affect in schizophrenic inpatients.
    Craig TJ; Richardson MA; Pass R; Bregman Z
    Am J Psychiatry; 1985 Nov; 142(11):1272-7. PubMed ID: 4061685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD
    Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.